Publications & Works

Publication Network

Published journal articles indexed by SCI, SSCI, and AHCI

Criteria for hyperinflammation developing in coronavirus disease-19: analysis of two cohorts from different periods of the pandemic.

Amikishiyev S., Gunver M. G., Bektas M., Aghamuradov S., Ince B., Koca N., et al.
Arthritis & rheumatology (Hoboken, N.J.), 2022 (SCI-Expanded) Sustainable Development identifier

Malnutrition treatment and follow-up in clinical nutrition outpatient clinics associated with increased muscle mass

Saka B., Bektas M., Bakkaloglu O. K., Amikishiyev S., Sarıbeyliler G., Tiryaki T. O., et al.
NUTRITION, vol.101, 2022 (SCI-Expanded) Sustainable Development identifier identifier identifier

Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls

Mert A., VAHABOĞLU H., ARSLAN F., Batirel A., Saracoglu K. T., Bastug A., et al.
RHEUMATOLOGY INTERNATIONAL, vol.42, no.3, pp.457-467, 2022 (SCI-Expanded) Sustainable Development identifier identifier identifier

Reinfection with SARS-CoV-2 in a kidney transplant recipient

Amikishiyev S., Demir E., Aghamuradov S., Garayeva N., Artan A. S., Gül A., et al.
TRANSPLANT INFECTIOUS DISEASE, vol.23, no.4, 2021 (SCI-Expanded) Sustainable Development identifier identifier identifier

Low concentrations of adropin are associated with endothelial dysfunction as assessed by flow-mediated dilatation in patients with metabolic syndrome

Oruc C. U., Akpinar Y. E., Dervisoglu E., Amikishiyev S., Salmaslioglu A., Gurdol F., et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, vol.55, no.1, pp.139-144, 2017 (SCI-Expanded) identifier identifier identifier

Hypovitaminosis D is Associated with Endothelial Dysfunction in Patients with Metabolic Syndrome

Oruc C. U., Akpinar Y. E., Amikishiyev S., Uzum A. K., Salmaslioglu A., Gurdol F., et al.
CURRENT VASCULAR PHARMACOLOGY, vol.15, no.2, pp.152-157, 2017 (SCI-Expanded) Sustainable Development identifier identifier identifier

Acquired FVIII and FIX Inhibitors after Pregnancy: A Case Report.

Kose M., Bakkaloglu O. K., Amikishiyev S., Akpinar T. S., Saracoglu B., Akcan T., et al.
Acta haematologica, vol.136, no.4, pp.229-232, 2016 (SCI-Expanded) identifier identifier identifier

Refereed Congress / Symposium Publications in Proceedings

Skleroderma Renal Krizi: Tek Merkezden izlenen Sistemik Sklerozlu Hastalarda Sıklığı ve Klinik Özellikleri

Alıyeva N., Yalçınkaya Y., Amıkıshıyev S., Artım Esen B., Gül A., İnanç M.
21.Ulusal Romatoloji Kongresi, Antalya, Turkey, 29 September - 03 October 2021

Sistemik Skleroz Hastalarında COVID-19 İnfeksiyonu Sıklığı Ve Seyri: Hastaneye Yatış Riskini Artıran Faktörler

Alıyeva N., Yalçınkaya Y., Amıkıshıyev S., Bektaş M., Cömert R. G., Artım Esen B., et al.
21.Ulusal Romatoloji Kongresi, Antalya, Turkey, 29 September - 03 October 2021 Sustainable Development

EVALUATION OF DIFFERENT CLASSIFICATION CRITERIA IN SYSTEMIC SCLEROSIS IN A TURKISH COHORT: THE IMPORTANCE OF NON-SKIN MANIFESTATIONS, SEROLOGY AND CAPILLAROSCOPY

Yalçınkaya Y., Amıkıshıyev S., Artım Esen B., Alıyeva N., Gül A., İnanç M.
european congress of rheumatology 2020, Frankfurt, Germany, 3 - 07 June 2020, pp.416

THE RELATIONSHIP BETWEEN DISEASE ACTIVITY AND SEVERITY IN SYSTEMIC SCLEROSIS: A PROSPECTIVE ANALYSIS OF 278 PATIENTS

Yalçınkaya Y., Alıyeva N., Amıkıshıyev S., Artım Esen B., Gül A., İnanç M.
european congress of rheumatology 2020, Frankfurt, Germany, 3 - 07 June 2020, pp.406

THE EFFICACY AND SAFETY OF RITUXIMAB IN 27 CASES OF TREATMENT RESISTANT SYSTEMIC SCLEROSIS WITH SEVERE DISEASE ASSESSED BY ACTIVITY SCORES

Yalçınkaya Y., Artım Esen B., Amıkıshıyev S., Alıyeva N., Gül A.
european congress of rheumatology 2020, Frankfurt, Germany, 3 - 07 June 2020, pp.1119

THE RELATIONSHIP BETWEEN DISEASE ACTIVITY AND SEVERITY IN SYSTEMIC SCLEROSIS: A PROSPECTIVE ANALYSIS OF 278 PATIENTS

YALÇINKAYA Y., ALIYEVA N., AMIKISHIYEV S., Cagatay Y., Artim-Esen B., GÜL A., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 June 2020, vol.79, pp.402 Creative Commons License identifier

EVALUATION OF DIFFERENT CLASSIFICATION CRITERIA IN SYSTEMIC SCLEROSIS IN A TURKISH COHORT: THE IMPORTANCE OF NON-SKIN MANIFESTATIONS, SEROLOGY AND CAPILLAROSCOPY

YALÇINKAYA Y., AMIKISHIYEV S., ALIYEVA N., Artim-Esen B., GÜL A., Ocal L., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 June 2020, vol.79, pp.412-413 identifier

THE EFFICACY AND SAFETY OF RITUXIMAB IN 27 CASES OF TREATMENT RESISTANT SYSTEMIC SCLEROSIS WITH SEVERE DISEASE ASSESSED BY ACTIVITY SCORES

YALÇINKAYA Y., Artim-Esen B., AMIKISHIYEV S., ALIYEVA N., GÜL A., Ocal L., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 June 2020, vol.79, pp.1115 identifier

Sınırlı sistemik skleroz ile takipli vakada gelişen santral sinir sistemi tutulumu özelliği

Amıkıshıyev S., Alıyeva N., Yalçınkaya Y., Artım Esen B., Gül A., İnanç M.
20.Ulusal Romatoloji, Antalya, Turkey, 16 - 20 October 2019, pp.222

Sistemik sklerozda yaygın ve sınırlı deri tutulumunda hastalık aktivitesi ile hastalık şiddeti ilişkisi: 278 hastanın prospektif kesitsel analizi

Yalçınkaya Y., Alıyeva N., Amıkıshıyev S., Artım Esen B., Gül A., İnanç M.
20.Ulusal Romatoloji, Antalya, Turkey, 16 - 20 October 2019, pp.30-31

Sistemik sklerozda sınıflandırma kriterlerinin de¤erlendirilmesi: Cilt dışı klinik bulgular, tırnak dibi kapillaroskopisi ve serolojinin önemi

Yalçınkaya Y., Amıkıshıyev S., Alıyeva N., Artım Esen B., Gül A., İnanç M.
20.Ulusal Romatoloji, Antalya, Turkey, 16 - 20 October 2019, pp.219-220

Tedaviye dirençli ve şiddetli seyirli 27 sistemik skleroz hastasında rituksimab tedavisinin etkinliği ve güvenilirliği

Yalçınkaya Y., Artım Esen B., Amıkıshıyev S., Alıyeva N., Gül A., İnanç M.
20. Ulusal Romatoloji, Antalya, Turkey, 16 - 20 October 2019, pp.218

Infectious epidemiology in Multiple Myeloma patients after Autologous Stem Cell Transplantation: A single-center analysis from Turkey

Amikishiyev S., Hindilerden I. Y., Erdem S., Aktan M., Nalcaci M., Sargin D., et al.
44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portugal, 18 - 21 March 2018, vol.53, pp.566-567 identifier